73
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Optimal timing of complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis

, , , , , & show all
Pages 1037-1051 | Published online: 24 Aug 2018

References

  • JensenLOTerkelsenCJHorváth-PuhóEInfluence of multives-sel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarctionAm Heart J20151701707826093866
  • LiuKLLinSMChangCHChenYCChuPHPlasma angiopoietin-1 level, left ventricular ejection fraction, and multivessel disease predict development of 1-year major adverse cardiovascular events in patients with acute ST elevation myocardial infarction - a pilot studyInt J Cardiol201518215516025577775
  • LevineGNBatesERBlankenshipJC2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and InterventionsCirculation2016133111135114726490017
  • IbanezBJamesSAgewallS2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)Eur Heart J201839211917728886621
  • HuttonBSalantiGCaldwellDMThe PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanationsAnn Intern Med20151621177778426030634
  • HigginsJPAltmanDGGøtzschePCThe Cochrane Collaboration’s tool for assessing risk of bias in randomised trialsBMJ2011343d592822008217
  • DersimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
  • HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
  • EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
  • ThorlundKEngstrmJWetterslevJBrokJImbergerGGluudCUser manual for Trial Sequential Analysis (TSA) Available from: http://www.ctu.dk/tsa/files/tsa_manual.pdfAccessed April 24, 2017
  • WetterslevJThorlundKBrokJGluudCTrial sequential analysis may establish when firm evidence is reached in cumulative meta-analysisJ Clin Epidemiol2008611647518083463
  • MillsEJThorlundKIoannidisJPDemystifying trial networks and network meta-analysisBMJ2013346f291423674332
  • DiasSSuttonAJAdesAEWeltonNJEvidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trialsMed Decis Making201333560761723104435
  • CooperNJSuttonAJLuGKhuntiKMixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillationArch Intern Med2006166121269127516801509
  • BrooksSPGelmanAGeneral methods for monitoring convergence of iterative simulationsJ Comput Graph Stat19987434455
  • van ValkenhoefGLuGde BrockBHillegeHAdesAEWel-tonNJAutomating network meta-analysisRes Synth Methods20123428529926053422
  • DiasSWeltonNJCaldwellDMAdesAEChecking consistency in mixed treatment comparison meta-analysisStat Med2010297–893294420213715
  • SalantiGAdesAEIoannidisJPGraphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorialJ Clin Epidemiol201164216317120688472
  • WoodsBSHawkinsNScottDANetwork meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorialBMC Med Res Methodol2010105420537177
  • DiasSSuttonAJWeltonNJAdesAEEvidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustmentMed Decis Making201333561864023804507
  • di MarioCMaraSFlavioASingle vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpa-coat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) StudyInt J Cardiovasc Intervent200463–412813316146905
  • WaldDSMorrisJKWaldNJRandomized trial of preventive angioplasty in myocardial infarctionN Engl J Med2013369121115112323991625
  • GershlickAHKhanJNKellyDJRandomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trialJ Am Coll Cardiol2015651096397225766941
  • HamzaMMahmoudNElgendyIYA randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multivessel diseaseJ Interv Cardiol201629324124727245121
  • SmitsPCAbdel-WahabMNeumannFJFractional flow reserve-guided multivessel angioplasty in myocardial infarctionN Engl J Med2017376131234124428317428
  • GhaniADambrinkJHvan ‘t HofAWOttervangerJPGosselinkATHoorntjeJCTreatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trialNeth Heart J201220934735322622701
  • HlinomazOGrochLPolokovaKPRAGUE 13: Multivessel PCI Failed to Best Culprit-Vessel PCI After STEMIParisEuroPCR2015
  • OchalaASmolkaGAWojakowskiWThe function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarctionJ Invasive Cardiol2004161269970215596873
  • RomanSTVladimirIGAlexeyVPOlgaLBLeonidSBSix month results of randomized clinical trial: multivessel stenting in primary percutaneous coronary intervention and staged revascularization for ST-elevation myocardial infarction patients with second generation drug eluting stentsClin Med Res201435125129
  • PolitiLSguraFRossiRA randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-upHeart201096966266719778920
  • EngstrømTKelbækHHelqvistSComplete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3 – PRIMULTI): an open-label, randomised controlled trialLancet2015386999466567126347918
  • MaamounWElkhaeatNElarasyRSafety and feasibility of complete simultaneous revascularization during primary PCI in patients with STEMI and multi-vessel diseaseEur Heart J20116313943
  • IjsselmuidenAJEzechielsJWestendorpICComplete versus culprit vessel percutaneous coronary intervention in multives-sel disease: a randomized comparisonAm Heart J2004148346747415389234
  • DambrinkJHDebrauwereJPvan ‘t HofAWNon-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?EuroIntervention20105896897520542783
  • HenriquesJPHoebersLPRåmunddalTPercutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trialJ Am Coll Cardiol201668151622163227712774
  • GuoWQLiLSuQMeta-analysis of strategies for patients with multivessel disease undergoing percutaneous coronary intervention: does the timing of staged procedures matter?JACC Cardiovasc Interv201710111180118128595887
  • KimIKimMCJeongHCOptimal timing of percutaneous coronary intervention for nonculprit vessel in patients with ST-segment elevation myocardial infarction and multivessel diseaseKorean Circ J2017471364328154589
  • IqbalMBNadraIJDingLCulprit vessel versus multivessel versus in-hospital staged intervention for patients with ST-segment elevation myocardial infarction and Multivessel disease: stratified analyses in high-risk patient groups and anatomic subsets of nonculprit diseaseJACC Cardiovasc Interv2017101112328057282
  • ThieleHAkinISandriMPCI strategies in patients with acute myocardial infarction and cardiogenic shockN Engl J Med2017377252419243229083953
  • StoneGWMaeharaALanskyAJA prospective natural-history study of coronary atherosclerosisN Engl J Med2011364322623521247313
  • TrelleSReichenbachSWandelSCardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysisBMJ2011342c708621224324
  • ParkCHJungYSNamEEunCSParkDIHanDSComparison of efficacy of prophylactic endoscopic therapies for postpolypectomy bleeding in the colorectum: a systematic review and network meta-analysisAm J Gastroenterol201611191230124327402502
  • AltmanDGBlandJMAbsence of evidence is not evidence of absenceBMJ199531170034857647644
  • ElgendyIYMahmoudANKumbhaniDJBhattDLBavryAAComplete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trialsJACC Cardiovasc Interv201710431532428231899
  • TarantiniGD’AmicoGBrenerSJSurvival after varying revas-cularization strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: a pairwise and network meta-analysisJACC Cardiovasc Interv20169171765177627609250
  • MoherDLiberatiATetzlaffJThe PRISMA Group (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementPLoS Med200967e100009719621072